Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Zenz

Showing results (71-80 of 183) with videos related to

Pageof 19
Sort By:
Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.
Blood|December 1, 2010
DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testingJulia Mohr, Hanne Helfrich, Maxi Fuge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
TP53 mutation and survival in chronic lymphocytic leukemiaThorsten Zenz, Barbara Eichhorst, Raymonde Busch, et al.
Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2011
Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cellsSascha Dietrich, Oliver H Krämer, Esther Hahn, et al.
Cancer Discovery|April 25, 2013
Targeting the BRAF V600E mutation in multiple myelomaMindaugas Andrulis, Nicola Lehners, David Capper, et al.
Cancers|June 12, 2026
A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 TrialMaria Cristina Pirosa, Dagmar Hess, Fatime Krasniqi, et al.
British Journal of Haematology|November 1, 2012
The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17pKe Lin, Brian Lane, Anthony Carter, et al.
Haematologica|November 2, 2023
SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolismFlorian Mayr, Vanessa Kruse, Dominik C Fuhrmann, et al.
Blood|July 29, 2011
A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignanciesKarl-Heinz Heider, Kerstin Kiefer, Thorsten Zenz, et al.
Pageof 19

Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.
Blood|December 1, 2010
DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testingJulia Mohr, Hanne Helfrich, Maxi Fuge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
TP53 mutation and survival in chronic lymphocytic leukemiaThorsten Zenz, Barbara Eichhorst, Raymonde Busch, et al.
Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2011
Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cellsSascha Dietrich, Oliver H Krämer, Esther Hahn, et al.
Cancer Discovery|April 25, 2013
Targeting the BRAF V600E mutation in multiple myelomaMindaugas Andrulis, Nicola Lehners, David Capper, et al.
Cancers|June 12, 2026
A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 TrialMaria Cristina Pirosa, Dagmar Hess, Fatime Krasniqi, et al.
British Journal of Haematology|November 1, 2012
The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17pKe Lin, Brian Lane, Anthony Carter, et al.
Haematologica|November 2, 2023
SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolismFlorian Mayr, Vanessa Kruse, Dominik C Fuhrmann, et al.
Blood|July 29, 2011
A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignanciesKarl-Heinz Heider, Kerstin Kiefer, Thorsten Zenz, et al.
Pageof 19